Global Anti-influenza Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Anti-influenza Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Anti-influenza Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-influenza Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Anti-influenza Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Anti-influenza Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Anti-influenza Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-influenza Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-influenza Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, HEC Pharm, Shanghai Zhongxisanwei, GlaxoSmithKline and Guangzhou Pharmaceutical and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Anti-influenza Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Anti-influenza Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-influenza Drugs, with revenue, gross margin and global market share of Anti-influenza Drugs from 2018 to 2023.
Chapter 3, the Anti-influenza Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Anti-influenza Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-influenza Drugs.
Chapter 13, to describe Anti-influenza Drugs research findings and conclusion.
This report is a detailed and comprehensive analysis for global Anti-influenza Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-influenza Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Anti-influenza Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Anti-influenza Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Anti-influenza Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-influenza Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-influenza Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, HEC Pharm, Shanghai Zhongxisanwei, GlaxoSmithKline and Guangzhou Pharmaceutical and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Anti-influenza Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oseltamivir
- Zanamivir
- Peramivir
- Other
- Children
- Adults
- Elderly
- Roche
- HEC Pharm
- Shanghai Zhongxisanwei
- GlaxoSmithKline
- Guangzhou Pharmaceutical
- Hunan Nucien Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Anti-influenza Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-influenza Drugs, with revenue, gross margin and global market share of Anti-influenza Drugs from 2018 to 2023.
Chapter 3, the Anti-influenza Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Anti-influenza Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-influenza Drugs.
Chapter 13, to describe Anti-influenza Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Anti-influenza Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-influenza Drugs by Type
1.3.1 Overview: Global Anti-influenza Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Anti-influenza Drugs Consumption Value Market Share by Type in 2022
1.3.3 Oseltamivir
1.3.4 Zanamivir
1.3.5 Peramivir
1.3.6 Other
1.4 Global Anti-influenza Drugs Market by Application
1.4.1 Overview: Global Anti-influenza Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Children
1.4.3 Adults
1.4.4 Elderly
1.5 Global Anti-influenza Drugs Market Size & Forecast
1.6 Global Anti-influenza Drugs Market Size and Forecast by Region
1.6.1 Global Anti-influenza Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Anti-influenza Drugs Market Size by Region, (2018-2029)
1.6.3 North America Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Anti-influenza Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Anti-influenza Drugs Product and Solutions
2.1.4 Roche Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 HEC Pharm
2.2.1 HEC Pharm Details
2.2.2 HEC Pharm Major Business
2.2.3 HEC Pharm Anti-influenza Drugs Product and Solutions
2.2.4 HEC Pharm Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 HEC Pharm Recent Developments and Future Plans
2.3 Shanghai Zhongxisanwei
2.3.1 Shanghai Zhongxisanwei Details
2.3.2 Shanghai Zhongxisanwei Major Business
2.3.3 Shanghai Zhongxisanwei Anti-influenza Drugs Product and Solutions
2.3.4 Shanghai Zhongxisanwei Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shanghai Zhongxisanwei Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Anti-influenza Drugs Product and Solutions
2.4.4 GlaxoSmithKline Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Guangzhou Pharmaceutical
2.5.1 Guangzhou Pharmaceutical Details
2.5.2 Guangzhou Pharmaceutical Major Business
2.5.3 Guangzhou Pharmaceutical Anti-influenza Drugs Product and Solutions
2.5.4 Guangzhou Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Guangzhou Pharmaceutical Recent Developments and Future Plans
2.6 Hunan Nucien Pharmaceutical
2.6.1 Hunan Nucien Pharmaceutical Details
2.6.2 Hunan Nucien Pharmaceutical Major Business
2.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Product and Solutions
2.6.4 Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hunan Nucien Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anti-influenza Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Anti-influenza Drugs by Company Revenue
3.2.2 Top 3 Anti-influenza Drugs Players Market Share in 2022
3.2.3 Top 6 Anti-influenza Drugs Players Market Share in 2022
3.3 Anti-influenza Drugs Market: Overall Company Footprint Analysis
3.3.1 Anti-influenza Drugs Market: Region Footprint
3.3.2 Anti-influenza Drugs Market: Company Product Type Footprint
3.3.3 Anti-influenza Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anti-influenza Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Anti-influenza Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anti-influenza Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Anti-influenza Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Anti-influenza Drugs Consumption Value by Type (2018-2029)
6.2 North America Anti-influenza Drugs Consumption Value by Application (2018-2029)
6.3 North America Anti-influenza Drugs Market Size by Country
6.3.1 North America Anti-influenza Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Anti-influenza Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Anti-influenza Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Anti-influenza Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Anti-influenza Drugs Consumption Value by Type (2018-2029)
7.2 Europe Anti-influenza Drugs Consumption Value by Application (2018-2029)
7.3 Europe Anti-influenza Drugs Market Size by Country
7.3.1 Europe Anti-influenza Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.3 France Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Anti-influenza Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anti-influenza Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Anti-influenza Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Anti-influenza Drugs Market Size by Region
8.3.1 Asia-Pacific Anti-influenza Drugs Consumption Value by Region (2018-2029)
8.3.2 China Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.5 India Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Anti-influenza Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Anti-influenza Drugs Consumption Value by Type (2018-2029)
9.2 South America Anti-influenza Drugs Consumption Value by Application (2018-2029)
9.3 South America Anti-influenza Drugs Market Size by Country
9.3.1 South America Anti-influenza Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Anti-influenza Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Anti-influenza Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anti-influenza Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Anti-influenza Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Anti-influenza Drugs Market Size by Country
10.3.1 Middle East & Africa Anti-influenza Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Anti-influenza Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Anti-influenza Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Anti-influenza Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Anti-influenza Drugs Market Drivers
11.2 Anti-influenza Drugs Market Restraints
11.3 Anti-influenza Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Anti-influenza Drugs Industry Chain
12.2 Anti-influenza Drugs Upstream Analysis
12.3 Anti-influenza Drugs Midstream Analysis
12.4 Anti-influenza Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Anti-influenza Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-influenza Drugs by Type
1.3.1 Overview: Global Anti-influenza Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Anti-influenza Drugs Consumption Value Market Share by Type in 2022
1.3.3 Oseltamivir
1.3.4 Zanamivir
1.3.5 Peramivir
1.3.6 Other
1.4 Global Anti-influenza Drugs Market by Application
1.4.1 Overview: Global Anti-influenza Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Children
1.4.3 Adults
1.4.4 Elderly
1.5 Global Anti-influenza Drugs Market Size & Forecast
1.6 Global Anti-influenza Drugs Market Size and Forecast by Region
1.6.1 Global Anti-influenza Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Anti-influenza Drugs Market Size by Region, (2018-2029)
1.6.3 North America Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Anti-influenza Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Anti-influenza Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Anti-influenza Drugs Product and Solutions
2.1.4 Roche Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 HEC Pharm
2.2.1 HEC Pharm Details
2.2.2 HEC Pharm Major Business
2.2.3 HEC Pharm Anti-influenza Drugs Product and Solutions
2.2.4 HEC Pharm Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 HEC Pharm Recent Developments and Future Plans
2.3 Shanghai Zhongxisanwei
2.3.1 Shanghai Zhongxisanwei Details
2.3.2 Shanghai Zhongxisanwei Major Business
2.3.3 Shanghai Zhongxisanwei Anti-influenza Drugs Product and Solutions
2.3.4 Shanghai Zhongxisanwei Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shanghai Zhongxisanwei Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Anti-influenza Drugs Product and Solutions
2.4.4 GlaxoSmithKline Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Guangzhou Pharmaceutical
2.5.1 Guangzhou Pharmaceutical Details
2.5.2 Guangzhou Pharmaceutical Major Business
2.5.3 Guangzhou Pharmaceutical Anti-influenza Drugs Product and Solutions
2.5.4 Guangzhou Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Guangzhou Pharmaceutical Recent Developments and Future Plans
2.6 Hunan Nucien Pharmaceutical
2.6.1 Hunan Nucien Pharmaceutical Details
2.6.2 Hunan Nucien Pharmaceutical Major Business
2.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Product and Solutions
2.6.4 Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hunan Nucien Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anti-influenza Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Anti-influenza Drugs by Company Revenue
3.2.2 Top 3 Anti-influenza Drugs Players Market Share in 2022
3.2.3 Top 6 Anti-influenza Drugs Players Market Share in 2022
3.3 Anti-influenza Drugs Market: Overall Company Footprint Analysis
3.3.1 Anti-influenza Drugs Market: Region Footprint
3.3.2 Anti-influenza Drugs Market: Company Product Type Footprint
3.3.3 Anti-influenza Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anti-influenza Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Anti-influenza Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anti-influenza Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Anti-influenza Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Anti-influenza Drugs Consumption Value by Type (2018-2029)
6.2 North America Anti-influenza Drugs Consumption Value by Application (2018-2029)
6.3 North America Anti-influenza Drugs Market Size by Country
6.3.1 North America Anti-influenza Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Anti-influenza Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Anti-influenza Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Anti-influenza Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Anti-influenza Drugs Consumption Value by Type (2018-2029)
7.2 Europe Anti-influenza Drugs Consumption Value by Application (2018-2029)
7.3 Europe Anti-influenza Drugs Market Size by Country
7.3.1 Europe Anti-influenza Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.3 France Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Anti-influenza Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Anti-influenza Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anti-influenza Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Anti-influenza Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Anti-influenza Drugs Market Size by Region
8.3.1 Asia-Pacific Anti-influenza Drugs Consumption Value by Region (2018-2029)
8.3.2 China Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.5 India Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Anti-influenza Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Anti-influenza Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Anti-influenza Drugs Consumption Value by Type (2018-2029)
9.2 South America Anti-influenza Drugs Consumption Value by Application (2018-2029)
9.3 South America Anti-influenza Drugs Market Size by Country
9.3.1 South America Anti-influenza Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Anti-influenza Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Anti-influenza Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anti-influenza Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Anti-influenza Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Anti-influenza Drugs Market Size by Country
10.3.1 Middle East & Africa Anti-influenza Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Anti-influenza Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Anti-influenza Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Anti-influenza Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Anti-influenza Drugs Market Drivers
11.2 Anti-influenza Drugs Market Restraints
11.3 Anti-influenza Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Anti-influenza Drugs Industry Chain
12.2 Anti-influenza Drugs Upstream Analysis
12.3 Anti-influenza Drugs Midstream Analysis
12.4 Anti-influenza Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Anti-influenza Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-influenza Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Anti-influenza Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Anti-influenza Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Anti-influenza Drugs Product and Solutions
Table 8. Roche Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. HEC Pharm Company Information, Head Office, and Major Competitors
Table 11. HEC Pharm Major Business
Table 12. HEC Pharm Anti-influenza Drugs Product and Solutions
Table 13. HEC Pharm Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. HEC Pharm Recent Developments and Future Plans
Table 15. Shanghai Zhongxisanwei Company Information, Head Office, and Major Competitors
Table 16. Shanghai Zhongxisanwei Major Business
Table 17. Shanghai Zhongxisanwei Anti-influenza Drugs Product and Solutions
Table 18. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Shanghai Zhongxisanwei Recent Developments and Future Plans
Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 21. GlaxoSmithKline Major Business
Table 22. GlaxoSmithKline Anti-influenza Drugs Product and Solutions
Table 23. GlaxoSmithKline Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. GlaxoSmithKline Recent Developments and Future Plans
Table 25. Guangzhou Pharmaceutical Company Information, Head Office, and Major Competitors
Table 26. Guangzhou Pharmaceutical Major Business
Table 27. Guangzhou Pharmaceutical Anti-influenza Drugs Product and Solutions
Table 28. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Guangzhou Pharmaceutical Recent Developments and Future Plans
Table 30. Hunan Nucien Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Hunan Nucien Pharmaceutical Major Business
Table 32. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product and Solutions
Table 33. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Hunan Nucien Pharmaceutical Recent Developments and Future Plans
Table 35. Global Anti-influenza Drugs Revenue (USD Million) by Players (2018-2023)
Table 36. Global Anti-influenza Drugs Revenue Share by Players (2018-2023)
Table 37. Breakdown of Anti-influenza Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Anti-influenza Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key Anti-influenza Drugs Players
Table 40. Anti-influenza Drugs Market: Company Product Type Footprint
Table 41. Anti-influenza Drugs Market: Company Product Application Footprint
Table 42. Anti-influenza Drugs New Market Entrants and Barriers to Market Entry
Table 43. Anti-influenza Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Anti-influenza Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global Anti-influenza Drugs Consumption Value Share by Type (2018-2023)
Table 46. Global Anti-influenza Drugs Consumption Value Forecast by Type (2024-2029)
Table 47. Global Anti-influenza Drugs Consumption Value by Application (2018-2023)
Table 48. Global Anti-influenza Drugs Consumption Value Forecast by Application (2024-2029)
Table 49. North America Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific Anti-influenza Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific Anti-influenza Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 79. Anti-influenza Drugs Raw Material
Table 80. Key Suppliers of Anti-influenza Drugs Raw Materials
Table 1. Global Anti-influenza Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-influenza Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Anti-influenza Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Anti-influenza Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Anti-influenza Drugs Product and Solutions
Table 8. Roche Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. HEC Pharm Company Information, Head Office, and Major Competitors
Table 11. HEC Pharm Major Business
Table 12. HEC Pharm Anti-influenza Drugs Product and Solutions
Table 13. HEC Pharm Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. HEC Pharm Recent Developments and Future Plans
Table 15. Shanghai Zhongxisanwei Company Information, Head Office, and Major Competitors
Table 16. Shanghai Zhongxisanwei Major Business
Table 17. Shanghai Zhongxisanwei Anti-influenza Drugs Product and Solutions
Table 18. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Shanghai Zhongxisanwei Recent Developments and Future Plans
Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 21. GlaxoSmithKline Major Business
Table 22. GlaxoSmithKline Anti-influenza Drugs Product and Solutions
Table 23. GlaxoSmithKline Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. GlaxoSmithKline Recent Developments and Future Plans
Table 25. Guangzhou Pharmaceutical Company Information, Head Office, and Major Competitors
Table 26. Guangzhou Pharmaceutical Major Business
Table 27. Guangzhou Pharmaceutical Anti-influenza Drugs Product and Solutions
Table 28. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Guangzhou Pharmaceutical Recent Developments and Future Plans
Table 30. Hunan Nucien Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Hunan Nucien Pharmaceutical Major Business
Table 32. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product and Solutions
Table 33. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Hunan Nucien Pharmaceutical Recent Developments and Future Plans
Table 35. Global Anti-influenza Drugs Revenue (USD Million) by Players (2018-2023)
Table 36. Global Anti-influenza Drugs Revenue Share by Players (2018-2023)
Table 37. Breakdown of Anti-influenza Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Anti-influenza Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key Anti-influenza Drugs Players
Table 40. Anti-influenza Drugs Market: Company Product Type Footprint
Table 41. Anti-influenza Drugs Market: Company Product Application Footprint
Table 42. Anti-influenza Drugs New Market Entrants and Barriers to Market Entry
Table 43. Anti-influenza Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Anti-influenza Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global Anti-influenza Drugs Consumption Value Share by Type (2018-2023)
Table 46. Global Anti-influenza Drugs Consumption Value Forecast by Type (2024-2029)
Table 47. Global Anti-influenza Drugs Consumption Value by Application (2018-2023)
Table 48. Global Anti-influenza Drugs Consumption Value Forecast by Application (2024-2029)
Table 49. North America Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific Anti-influenza Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific Anti-influenza Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa Anti-influenza Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa Anti-influenza Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa Anti-influenza Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa Anti-influenza Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa Anti-influenza Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa Anti-influenza Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 79. Anti-influenza Drugs Raw Material
Table 80. Key Suppliers of Anti-influenza Drugs Raw Materials
LIST OF FIGURES
Figure 1. Anti-influenza Drugs Picture
Figure 2. Global Anti-influenza Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-influenza Drugs Consumption Value Market Share by Type in 2022
Figure 4. Oseltamivir
Figure 5. Zanamivir
Figure 6. Peramivir
Figure 7. Other
Figure 8. Global Anti-influenza Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Anti-influenza Drugs Consumption Value Market Share by Application in 2022
Figure 10. Children Picture
Figure 11. Adults Picture
Figure 12. Elderly Picture
Figure 13. Global Anti-influenza Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Anti-influenza Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Anti-influenza Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Anti-influenza Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Anti-influenza Drugs Consumption Value Market Share by Region in 2022
Figure 18. North America Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Anti-influenza Drugs Revenue Share by Players in 2022
Figure 24. Anti-influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Anti-influenza Drugs Market Share in 2022
Figure 26. Global Top 6 Players Anti-influenza Drugs Market Share in 2022
Figure 27. Global Anti-influenza Drugs Consumption Value Share by Type (2018-2023)
Figure 28. Global Anti-influenza Drugs Market Share Forecast by Type (2024-2029)
Figure 29. Global Anti-influenza Drugs Consumption Value Share by Application (2018-2023)
Figure 30. Global Anti-influenza Drugs Market Share Forecast by Application (2024-2029)
Figure 31. North America Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. France Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Anti-influenza Drugs Consumption Value Market Share by Region (2018-2029)
Figure 48. China Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. India Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Anti-influenza Drugs Market Drivers
Figure 66. Anti-influenza Drugs Market Restraints
Figure 67. Anti-influenza Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Anti-influenza Drugs in 2022
Figure 70. Manufacturing Process Analysis of Anti-influenza Drugs
Figure 71. Anti-influenza Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Anti-influenza Drugs Picture
Figure 2. Global Anti-influenza Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-influenza Drugs Consumption Value Market Share by Type in 2022
Figure 4. Oseltamivir
Figure 5. Zanamivir
Figure 6. Peramivir
Figure 7. Other
Figure 8. Global Anti-influenza Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Anti-influenza Drugs Consumption Value Market Share by Application in 2022
Figure 10. Children Picture
Figure 11. Adults Picture
Figure 12. Elderly Picture
Figure 13. Global Anti-influenza Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Anti-influenza Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Anti-influenza Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Anti-influenza Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Anti-influenza Drugs Consumption Value Market Share by Region in 2022
Figure 18. North America Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Anti-influenza Drugs Revenue Share by Players in 2022
Figure 24. Anti-influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Anti-influenza Drugs Market Share in 2022
Figure 26. Global Top 6 Players Anti-influenza Drugs Market Share in 2022
Figure 27. Global Anti-influenza Drugs Consumption Value Share by Type (2018-2023)
Figure 28. Global Anti-influenza Drugs Market Share Forecast by Type (2024-2029)
Figure 29. Global Anti-influenza Drugs Consumption Value Share by Application (2018-2023)
Figure 30. Global Anti-influenza Drugs Market Share Forecast by Application (2024-2029)
Figure 31. North America Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. France Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Anti-influenza Drugs Consumption Value Market Share by Region (2018-2029)
Figure 48. China Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. India Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Anti-influenza Drugs Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Anti-influenza Drugs Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Anti-influenza Drugs Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Anti-influenza Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Anti-influenza Drugs Market Drivers
Figure 66. Anti-influenza Drugs Market Restraints
Figure 67. Anti-influenza Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Anti-influenza Drugs in 2022
Figure 70. Manufacturing Process Analysis of Anti-influenza Drugs
Figure 71. Anti-influenza Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
